Factors influencing the CNS distribution of a novel MEK-1/2 inhibitor: Implications for combination therapy for melanoma brain metastases

Shruthi Vaidhyanathan, Rajendar K. Mittapalli, Jann N. Sarkaria, William F. Elmquist

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Factors influencing the CNS distribution of a novel MEK-1/2 inhibitor: Implications for combination therapy for melanoma brain metastases'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds